These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7532557)

  • 1. Partial characterization of a 52 kDa CsA/FK506/rapamycin binding protein.
    Donnelly JG; Soldin SJ
    Clin Biochem; 1994 Oct; 27(5):367-72. PubMed ID: 7532557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 14 kDa FK-506/rapamycin binding immunophilin from calf thymus.
    Murthy JN; Chen Y; Soldin SJ
    Clin Biochem; 1994 Oct; 27(5):357-65. PubMed ID: 7532556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemistry of signal transduction.
    Clardy J
    Proc Natl Acad Sci U S A; 1995 Jan; 92(1):56-61. PubMed ID: 7529414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506-binding protein mutational analysis: defining the active-site residue contributions to catalysis and the stability of ligand complexes.
    DeCenzo MT; Park ST; Jarrett BP; Aldape RA; Futer O; Murcko MA; Livingston DJ
    Protein Eng; 1996 Feb; 9(2):173-80. PubMed ID: 9005438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a 37 kDa tacrolimus, sirolimus and cyclosporine binding immunophilin possessing glyceraldehyde 3-phosphate dehydrogenase activity isolated from the Jurkat T cell line.
    Murthy JN; Goodyear N; Soldin SJ
    Clin Biochem; 1997 Mar; 30(2):129-33. PubMed ID: 9127694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 8. Analogous conformations of both binding and effector regions in cyclosporin A, FK506 and rapamycin.
    Denesyuk AI; Denessiouk KA; Zav'yalov VP; Lundell J; Korpela T
    Comput Chem; 1998 Jun; 22(4):339-44. PubMed ID: 9680690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor (immunophilin-binding) assay for immunosuppressive drugs.
    Soldin SJ
    Ther Drug Monit; 1995 Dec; 17(6):574-6. PubMed ID: 8588223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B; Weber E; Mihatsch MJ
    Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus.
    Lane WS; Galat A; Harding MW; Schreiber SL
    J Protein Chem; 1991 Apr; 10(2):151-60. PubMed ID: 1718307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional structure and actions of immunosuppressants and their immunophilins.
    Braun W; Kallen J; Mikol V; Walkinshaw MD; Wüthrich K
    FASEB J; 1995 Jan; 9(1):63-72. PubMed ID: 7529736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons from molecular matchmakers.
    Teague S
    Nat Struct Biol; 1995 May; 2(5):360-1. PubMed ID: 7545076
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein.
    Koltin Y; Faucette L; Bergsma DJ; Levy MA; Cafferkey R; Koser PL; Johnson RK; Livi GP
    Mol Cell Biol; 1991 Mar; 11(3):1718-23. PubMed ID: 1996117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FK506 binding protein mutational analysis. Defining the surface residue contributions to stability of the calcineurin co-complex.
    Futer O; DeCenzo MT; Aldape RA; Livingston DJ
    J Biol Chem; 1995 Aug; 270(32):18935-40. PubMed ID: 7642551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational polymorphism in peptidic and nonpeptidic drug molecules.
    Taylor P; Mikol V; Kallen J; Burkhard P; Walkinshaw MD
    Biopolymers; 1996; 40(5):585-92. PubMed ID: 9101762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex.
    Wiederrecht G; Hung S; Chan HK; Marcy A; Martin M; Calaycay J; Boulton D; Sigal N; Kincaid RL; Siekierka JJ
    J Biol Chem; 1992 Oct; 267(30):21753-60. PubMed ID: 1383226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast immunophilins: purification and assay of yeast FKBP12.
    Wiederrecht G; Siekierka JJ
    Methods Enzymol; 1998; 290():74-84. PubMed ID: 9534152
    [No Abstract]   [Full Text] [Related]  

  • 20. Isolation and amino acid sequence of a new 22-kDa FKBP-like peptidyl-prolyl cis/trans-isomerase of Escherichia coli. Similarity to Mip-like proteins of pathogenic bacteria.
    Rahfeld JU; Rücknagel KP; Stoller G; Horne SM; Schierhorn A; Young KD; Fischer G
    J Biol Chem; 1996 Sep; 271(36):22130-8. PubMed ID: 8703024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.